D/A

Amended Notice of Exempt Offering of Securities

Clover Biopharmaceuticals, Ltd. Filed 2022-05-24 Acc 0001104659-22-064094

Documents 1

D/A Amended Notice of Exempt Offering of Securities , xslFormDX01/primary_doc.xml

Around this filing

2023-05-09 D/A Amended Notice of Exempt Offering of Securities
2022-05-24 D/A Amended Notice of Exempt Offering of Securities

Link to a passage

External

SEC EDGAR (opens in new tab)